Recent Headlines
CalStop™ Named Weight Loss Supplement of the Year 2026
Norwegian-developed supplement recognised for science-aligned approach to appetite control and weight management. - April 23, 2026 - Nordics Co AS
International Vitamin Corporation to Be Featured on Now We Know! with Steve Guttenberg – Airing April 18 on CNBC
The upcoming episode of Now We Know! with SteveGuttenberg, airing April 18 at 11a ET on CNBC, will feature International Vitamin Corporation, a company specializing in the development and manufacturing of vitamins, supplements, and nutritional products. - April 17, 2026 - International Vitamin Corporation
Aldevron Named 2026 CDMO Leadership Awards Winner in the Small/Mid-Size Cell & Gene Therapy Category
Aldevron has been recognized as a 2026 CDMO Leadership Awards Winner in the Small/Mid-Size Cell & Gene Therapy category. The CDMO Leadership Awards, presented by Outsourced Pharma and Life Science Connect, are widely regarded as one of the most credible benchmarks of CDMO performance in the biopharma industry. Now in their 15th year, the awards are based entirely on verified feedback. - April 14, 2026 - Aldevron
International Vitamin Corporation Recognized by Food Business Review as Top Private Label Supplement Manufacturer 2026
International Vitamin Corporation (IVC), a leading global manufacturer of vitamins, minerals, and supplements, has been recognized as the Top Private Label Supplement Manufacturer 2026 by Food Business Review. This recognition reflects IVC’s leadership in accelerating speed-to-market and... - April 13, 2026 - International Vitamin Corporation
Alera Bio Announces Exclusive Licensing Agreement with BLA Technology to Expand Thyroid Hormone Intellectual Property Portfolio
Alera Bio has secured an exclusive global license from BLA Technology, LLC for thyroid hormone-related IP, strengthening its platform for MCT-8 deficiency. The deal expands Alera’s ability to target both neurological and systemic disease drivers, supports its lead program AB-101, reduces development risk, and enables future pipeline growth. - April 09, 2026 - Alera Bio
Alera Bio Appoints Andrew Eisen, MD, PhD, as Chief Scientific Officer
Alera Bio has appointed Andrew Eisen, MD, PhD, as Chief Scientific Officer, bringing over 20 years of experience in translational medicine and clinical development. With deep expertise in neuroscience, metabolic disease, and myelination, Dr. Eisen will lead the advancement of Alera’s lead program, AB-101, and help drive its mission to develop transformative therapies for patients with severe neurological disorders, including MCT-8 deficiency. - April 08, 2026 - Alera Bio
GENINVO Introduces CodeMagic: AI‑Assisted Code Generation for Statistical Programming
GENINVO, a leading provider of transformative digital solutions for the life sciences sector, proudly announces the launch of CodeMagic, an innovative AI‑assisted coding platform designed to accelerate and simplify statistical programming across clinical research and pharmaceutical... - April 05, 2026 - GenInvo, Inc.
Brain Healing, Inc. Receives FDA Humanitarian Use Device (HUD) Designation for MELAS
Non-invasive biophoton platform advances toward HDE pathway for rare mitochondrial disease - April 01, 2026 - Tesla BioHealing, Inc.
Best Joint Supplement: Movanze™ Wins Award
Best joint supplement is the title Movanze™ has now been awarded in Norway for 2026, after being recognized with the distinction “Best Joint Support Supplement of the Year, Norway 2026” in the Logistics & Supply Chain Awards, conducted by Global Brands Magazine. - March 31, 2026 - Nordics Co AS
SignaBlok Receives Orphan Drug Designation from FDA for a First-in-Class TREM-1 Peptide Inhibitor for the Treatment of Retinopathy of Prematurity
SignaBlok, Inc., a preclinical stage biotechnology company pioneering novel, first-in-class peptide therapies for multiple inflammation-associated diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the Company’s TREM-1 peptide... - March 27, 2026 - SignaBlok, Inc.
SignaBlok to Present Novel Approach to Preventing Cancer Recurrence at the 2026 American Association for Cancer Research (AACR) Annual Meeting
• In experimental pancreatic cancer, macrophage-targeted but not cell-unspecific TREM-1 inhibitor: 1) prevents cancer recurrence, improves complete response rate and survival, when administered in a time window of 7 days after standard-of-care (SOC) chemotherapy, and 2) reverses immunosuppression and overcomes cancer resistance to anti-PD-L1 immunotherapy - March 26, 2026 - SignaBlok, Inc.
Longevity Rx Partners with Equinox Hotels to Bring Clinical-Grade Cellular Health Supplements to Luxury Hospitality
Dr. Will Cole's functional medicine-backed supplement brand joins Equinox Hotels' curated high-performance offering at the flagship Hudson Yards location. - March 17, 2026 - Longevity Rx
Industry Legend Bodybuilding.com Launches Bodybuilding Health Plus, Expanding into Personalized Metabolic, Wellness, and Quality-of-Life Support
Bodybuilding.com, a trusted leader in fitness and performance for over two decades, today announced the launch of Bodybuilding Health Plus, a new service designed to expand access to personalized health and wellness solutions. The platform introduces innovative offerings in metabolic health,... - March 16, 2026 - Bodybuilding.com
Bodybuilding.com Announces Bodybuilding Health Plus Partnership
Bodybuilding.com today announced its new health services partnership. The launch of Bodybuilding Health Plus will officially go live on March 16, marking a significant expansion into personalized metabolic, wellness, and sexual health support. Bodybuilding Health Plus broadens the company’s... - March 14, 2026 - Bodybuilding.com
Liquet™ Medical Receives Second FDA 510(k) Clearance for Versus™ Catheter
Expands Hemodynamics-Led Thrombolysis (HLT) Platform and Unlocks New Interventional Segment. - March 05, 2026 - Liquet Medical Inc.
Komal Medical Launches Direct Dawai for Online Pharmacy in Jaipur
Komal Medical & Provision Store is a familiar and trusted name in Jaipur. The store has a strong presence in the city, not for now, but for many years. It is known for its reliable service and genuine medicine, with an aim for maximum client satisfaction. Daily, hundreds of people buy... - February 28, 2026 - Direct Dawai
Thar Process Unveils New Line of CO2 Bulk Delivery Systems for Any Prep SFC and Pilot Scale SFE Users
Thar has a 35-year history of building automated supercritical systems and operating R&D labs. For many years, Thar also built CO2 delivery systems to make it easier for any client to access CO2 without the inconvenience of CO2 bottles/tanks inside the lab. This automation provides a fast return on investment for company's trying to mitigate labor costs and safety risks. - February 13, 2026 - Thar Process
Infinite Labs Solves Supplement Industry's Biggest Problem: Poor Absorption with Clinically-Proven Liposomal Technology
Infinite Labs launches clinically-proven liposomal supplement line with 10X better absorption than traditional supplements. Backed by six peer-reviewed studies, the technology achieves 67% faster cellular delivery and 90%+ encapsulation efficiency. Four formulas now available: Vitamin C+, Glutathione+, Magnesium+, and Vitamin D3 & K2+. - January 31, 2026 - Infinite Labs
I Holland Celebrates 80 Years of Excellence with a Global Series of Free Seminars
In 2026, I Holland proudly reaches an exciting milestone: 80 years of excellence in tablet compression tooling. Founded in 1946, I Holland has spent eight decades advancing tablet compression technology, sharing industry-leading expertise, and supporting customers around the world. To celebrate... - January 29, 2026 - I Holland Ltd.
CanVeer Biopharma Accepted Into Prestigious Intellectual Property Ontario (IPON) Program to Advance IP Strategy for Neonatal Therapy
CanVeer has been accepted into the highly competitive & prestigious Intellectual Property Ontario (IPON) Program. Through IPON CanVeer is eligible to receive up to CAD $300,000 in lifetime funding (on an 80% cost-share basis) to strengthen its intellectual property portfolio for its lead asset AlveoShield™. The program also grants access to expert advisory services in IP strategy, commercialization, training, and portfolio development. - January 28, 2026 - CanVeer Biopharma Inc.
CalStop™ Named Weight-Loss Supplement of the Year
CalStop™ has been awarded “Weight-loss Supplement of the Year” at the Global Brands Magazine Awards 2025, reinforcing the product’s position as a science-aligned and quality-focused brand within the weight-management supplement category. - January 16, 2026 - Nordics Co AS
Qinecsa Signals Next Growth Chapter with Appointment of Alex Livingstone-Learmonth as Chief Commercial Officer
Alex will drive global commercial strategy and help scale Qinecsa’s next-generation pharmacovigilance technology across the life sciences ecosystem. - January 16, 2026 - Qinecsa Solutions
CanVeer Biopharma Launches Validation Program for Flagship Neonatal Therapeutic and Appoints Executive Team
CanVeer announces the launch of the validation program for its flagship product, AlveoShield™ (Investigational New Drug). The program targets preterm newborns with or at risk of developing bronchopulmonary dysplasia (BPD). Bronchopulmonary dysplasia is a chronic respiratory disease affecting preterm neonates who require assisted ventilation. AlveoShield™ is designed to potentially prevent and treat BPD. CanVeer also announces the appointment of Sherif Louis as CEO and Behzad Yeganeh as CSO. - January 13, 2026 - CanVeer Biopharma Inc.
Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida’s Fastest-Growing Healthcare Corridor
Pharmacy XD LLC, a fully licensed Florida Department of Health–approved national mail order pharmacy and distribution facility, today officially announces its direct-to-patient (DTP) platform. Positioned in the heart of one of Florida’s most dynamic healthcare and life sciences... - January 08, 2026 - Pharmacy XD LLC
Cumberland Biotherapeutics Announces U.S. Launch of FDA Cleared DentoClude F, Complimentary Practice Program, and New Investor Fundraising Initiative
Cumberland Biotherapeutics, LLC, a dental innovation company integrating advanced bioactive glass with botanicals, today announced the U.S. launch of DentoClude F; DentoClude F is marketed under a commercial name for the Occlude® F Dentin Tubule Agent, which received FDA 510(k) clearance under... - December 30, 2025 - Cumberland Biotherapeutics, Inc
Nudge Establishes Leadership in 10% Nano Hydroxyapatite Toothpaste with Advanced REMIN+ Enamel Formula
Nudge, an Orlando, Florida–based oral care brand, advances fluoride free enamel care with its Nano Hydroxyapatite REMIN+ toothpaste, formulated around a high concentration 10% nano hydroxyapatite framework. Built by oral care experts with a passion over profits mindset, Nudge focuses on science backed formulation, transparency, and long term oral health. - December 29, 2025 - Nudge
Fleming Event Launches: In-Line Inspection and Inspection of Challenging Pipelines, 10–13 March 2026 in Amsterdam.
Pipeline Integrity Enters a New Risk Era - Inspection of Challenging Pipelines, 10–13 March 2026 in Amsterdam - December 19, 2025 - Fleming Events
Fleming Events Launches: Process Control Week: PID Tuning & Advanced Process Control Training, 9–13 March 2026, Amsterdam
Process Industries Face Rising Demand for Precision Control, Energy Efficiency, and Advanced Automation - December 19, 2025 - Fleming Events
Creative BioMart Enhances Host Cell Protein Mitigation Service to Strengthen Biotherapeutic Quality
Creative BioMart, a leading biotechnology company specializing in protein and biopharmaceutical solutions, has announced an enhancement to its host cell protein service. The upgraded offering introduces a more integrated and data-driven approach to identifying, quantifying, and reducing host cell... - December 11, 2025 - Creative BioMart
iFyber Expands Analytical Capabilities with Launch of Advanced LC-MS Services
iFyber has expanded its LC-MS analytical capabilities with advanced Orbitrap and UHPLC technology and the addition of industry experts Gary Schultz, PhD, and Brian Hoffman. The enhanced platform boosts sensitivity and analytical depth, supporting proteomics, metabolomics, E&L, and contaminant testing, strengthening iFyber’s mission to deliver high-quality, decision-driving preclinical insights. - December 10, 2025 - iFyber
Elabscience® Announces Antibody Technology Upgrade and Product Portfolio Enhancement
Elabscience® has announced a major upgrade to its antibody product portfolio with the adoption of recombinant rabbit monoclonal antibody technology. This innovation significantly enhances antibody specificity, reproducibility, and stability, meeting the growing global demand for high-performance research reagents. - November 19, 2025 - Elabscience
Botanical Advocacy and Education (BAE) Launches to Promote Pure, Safe and Natural Solutions for Public Health
Botanical Advocacy and Education’s goal is to educate all people to the truth about botanicals. BAE is a Nonprofit that has been formed to reenergize Grassroots Advocacy and Education for the purpose of protecting the right of all American adults to use natural, unadulterated Botanicals for the purposes they choose. - November 17, 2025 - Botanical Advocacy and Education
Parvus Therapeutics Reports Positive Phase 1 Results for Lead Autoimmune Treg Therapy, PVT201
PVT201 demonstrated favorable safety, predictable pharmacokinetics, and on-target pharmacodynamic activity in first-in-human study. - November 12, 2025 - Parvus Therapeutics U.S., Inc.
Healing the Invisible Wounds of War: Veterans Rebuild Lives After Combat
From the battlefield to civilian life, veterans reveal how understanding the mind helped them overcome post-service stress. - November 11, 2025 - Bridge Publications
Alera Bio Announces Appointment of Board of Directors
Alera Bio, a Chicago-based biotech developing therapies for rare neuroendocrine and neurological disorders, announced its inaugural Board of Directors. The board includes leaders in biopharma, clinical practice, and finance, such as Stephen Hill, Mark Prygocki, Renny Griffith, and Cassius Coleman. Their combined expertise will guide Alera Bio as it advances AB-101 for MCT-8 deficiency, an FDA-designated Rare Pediatric Disease therapy. - November 11, 2025 - Alera Bio
MVT Reports Breakthrough Preclinical Results for MVT‑101 in DVT Model
Microvascular Therapeutics, Inc. (MVT) today announced the publication of compelling preclinical data demonstrating that its proprietary phase‑shift microbubble platform, MVT‑101 (Solv), significantly enhances sonothrombolysis in a clinically relevant porcine model of deep vein thrombosis (DVT). The study appears in the peer‑reviewed journal Nanotheranostics (Vol. 9, Issue 3, 2025). - November 04, 2025 - Microvascular Therapeutics, Inc.
True Marker Pharmaceuticals Hits Another Trust & Credibility Milestone
True Marker Pharmaceuticals, Inc., a licensed pharmaceutical wholesaler and repackager based in Phoenix, has earned BBB Accreditation, recognizing its commitment to ethical business practices, transparency, and regulatory compliance. The achievement aligns with True Marker’s expanding U.S. distribution network and reinforces its reputation as a trusted, DSCSA-compliant partner to independent pharmacies and healthcare providers nationwide. - October 28, 2025 - True Marker Pharmaceuticals, Inc.
Fleming Events Launches “Digital Quality in Clinical Trials” Training to Address New ICH E6 (R3) GCP Expectations
Fleming Events, a global provider of professional training and industry knowledge programs, has announced its upcoming masterclass Digital Quality in Clinical Trials, scheduled for 22–23 April 2026 in Vienna, Austria. The training comes at a critical time as regulators worldwide increase... - October 28, 2025 - Fleming Events
Finetech Updates All Plastic Ampoule Filling Machines; Now Introduces 1 New Series of Machines
Finetech has launched a new line of plastic ampoule filling machines designed to meet small-dose filling needs, suitable for filling solutions for test drugs, cosmetics, health products and food. - October 27, 2025 - Finetech
New Report Uncovers What Sponsors Really Think About Preclinical Services and CROs
Life Science Strategy Group’s Preclinical Services Landscape and CRO Benchmarking Assessment Delivers Data-Driven Insights on Budgets, Outsourcing, Vendor Preferences, and Industry Shifts - October 16, 2025 - Life Science Strategy Group, LLC
IVC Hosts Charity Golf Tournament, Donates $100,000 to Support Local Communities
IVC proudly hosted its annual Charity Golf Tournament on October 8 at The Cliffs at Mountain Park Golf Club, bringing together employees, partners, and community members for a day of camaraderie, giving, and impact. As part of the event, IVC donated $50,000 each to March of Dimes in Anderson, SC,... - October 11, 2025 - International Vitamin Corporation
Radial Celebrates the Grand Opening of Its Second South Carolina Clinic in Downtown Conway
More than 60 community members and business leaders join for ribbon cutting ceremony with the Conway Chamber of Commerce. - October 11, 2025 - Radial
Alera Bio Announces Appointment of Executive Leadership Team
Alera Bio announced its executive team: Philip Vorhies (CEO), Peter Thomson (CFO), Eric Floyd, PhD (CRO), and Caitlin Murray (GC), supported by expert consultants. Founder Frank Jaeger noted their strength in biotech, finance, regulatory, and legal, positioning Alera to advance AB-101 for MCT-8 deficiency, a rare neurological disorder with FDA Rare Pediatric Disease designation. - September 26, 2025 - Alera Bio
Madison Avenue Group Announces Christine Nguyen as Official Partner
In 2021, Madison Avenue Group was founded with a clear mission: to help brands scale and grow through the power of influencer marketing. What began as a solo venture by founder Hollie Nguyen has now grown into a partnership built on strength, resilience, and vision. - September 26, 2025 - Madison Ave Group
Natural Cure Labs’ Level Off Gains Traction as Americans Seek Metabolic Health
Natural Cure Labs has updated its Level Off glucose support supplement to include loquat leaf extract, expanding the formula’s evidence base for healthier post-meal glucose balance. With only 12% of U.S. adults metabolically healthy, the enhancement underscores rising demand for natural solutions. - September 24, 2025 - Natural Cure Labs
French Biotech 4Dcell Selected to Showcase Next-Gen Cardiac Drug Testing Platform at EIC Corporate Day
French Startup 4Dcell Wins Spot to Show Next-Gen Cardiac Drug Testing Platform at EIC - September 24, 2025 - 4Dcell
YOLO Immune Awarded National Science Foundation SBIR Grant to Advance Novel Immunotherapy for the Treatment of Autoimmune Diseases
YOLO Immune, Inc., a venture-backed biotech company developing precision immunotherapies for the treatment of serious human diseases, today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The NSF SBIR program is... - September 19, 2025 - YOLO Immune Inc
Alera Bio Launches Lead Rare Disease Program with Exclusive Rights to MCT-8 Deficiency Therapy
Alera Bio secures exclusive license to advance AB-101, a first-in-class program for MCT-8 deficiency, with FDA Rare Pediatric Disease designation already in place. - September 18, 2025 - Alera Bio
Dr. David Pincus of Pincus Plastic Surgery Named #1 Plastic Surgeon in New York and Florida by Hippo Medical
Board-Certified Plastic Surgeon Dr. David Pincus, founder of Pincus Plastic Surgery, has been honored with the America’s Top Plastic Surgeon Award by Hippo Medical, recognizing him as the #1 plastic surgeon in both New York and Florida for his excellence in patient safety, surgical artistry, and natural aesthetic results. - September 17, 2025 - Pincus Plastic Surgery
Longevity World Cup Launches: A Global Sport Where Age is the Advantage
The Longevity World Cup, launching September 16, 2025, is the first global competition where athletes win by reversing their biological age. Rankings are based on verified tests using the PhenoAge clock, with categories by gender and generation. Prize money, funded in Bitcoin, goes to the top athletes. - September 16, 2025 - Longevity World Cup